🎄🌟 🎉 Wishing our readers a Merry Christmas and a Happy New Year filled with new possibilities ! 🎄🌟 🎉
🎄🌟 🎉 Wishing our readers a Merry Christmas and a Happy New Year filled with new possibilities ! 🎄🌟 🎉

Thursday, 26 December 2024

  1. Pharma
  2. BioPharma
  3. Drugs Going Off Patent

Drugs Going Off Patent

11 November 2005 | News

Biogenerics market gaining momentum
Drugs Going Off Patent
 S.No Brand Generic Name Company US Patent
  Name      Expiry
1 Claritin Loratadine Antihistamine Schering-Plough 2002
2 Augmentin Amoxicillin/clavulanate    
    potassium GlaxoSmithKline 2002
3 Intron A Interferon alpha-2b Schering-Plough 2002
4 Axid   Eli Lilly 2002
5 Relafen Nabumetone GlaxoSmithKline 2002
6 Avonex Interferon beta-1a Biogen 2003
7 Humatrope Somatropin Eli Lilly 2003
8 Singulair Montelukast sodium Merck & Co. 2003
9 Flovent Fluticasone propionate GlaxoSmithKline 2003
10 Flonase Fluticasone propionate GlaxoSmithKline 2003
11 Engerix-B   GlaxoSmithKline 2003
12 Nutropin Somatropin Genentech 2003
13 Lovenox Enoxaparin sodium Aventis Pharmaceuticals    2004
14 Diflucan   Pfizer 2004
15 Cipro   Bayer 2004
16 Lupron Leuprolide acetate Tap Pharmaceutical 2004
17 Lamisil Terbinafine hydrochloride Novartis Pharmaceuticals  2004
18 Paraplatin Carboplatin Bristol-Myers Squibb 2004
19 Xenical Orlistat Roche Laboratories 2004
20 Epogen Epoetin alfa Amgen, Johnson  
  or Procrit   & Johnson, and Sankyo 2004
21 Zocor Simvastatin Merck & Co. 2005
22 Prevacid Lansoprazole Tap Pharmaceutical 2005
23 Zoloft Sertraline hydrochloride Pfizer 2005
24 Pravachol Pravastatin Bristol-Myers Squibb 2005
25 Zithromax Azithromycin Pfizer 2005
26 Biaxin Clarithromycin Abbott Laboratories 2005
27 Zofran Ondansetron hydrochloride GlaxoSmithKline 2005

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Other Topics

Leadership

image credit- shutterstock

BioPharma’s Transformative & S...

Innovations in Urological Imag...
image credit- shutterstock

What’s dampening the Global AM...

Indian Lifesciences Industry G...
image credit- shutterstock

HIV Prevention Remains Elusive...

How strategic angel investment...

TRENDING TOPICS

image credit- shutterstock

Early Diabetic Retinopathy Det

Impact of Digital Transformati
image credit- pib

Govt announces launch of 4 CoE

PM inaugurates Lyfius Pharma’s





Most read

UCL and IISc join forces to co-crea

Medtronic launches US FDA approved

IIT Kharagpur partners with z21 Ven

Samsung R&D Institute, Noida and II

Survey Box

Is the Indian BioPharma sector ready for a Transformative & Strategic Outlook in 2025?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls

Subscribe to BioSpectrum India

Enquiry

Contact Us

MMA

Ashirwad Bungalow, First floor,
36/A/2, S.No. 270, Pallod Farms,
Near Bank of Baroda, Baner Road,
Pune, Maharashtra, India 411045

Mob : +91-9579069369

Email : communications@mmactiv.com

**Disclaimer

Visit Our Digital Magazine :

BioSpectrum Asia

NuFFooDS Spectrum

Sitemap

© 2024 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer

Web Interface Conceived and Powered By : SCI Knowledge Interlinks